Participants 0 54 4
Treatment of adults with acute lymphoblastic leukemia:
Participants 153 221 3
Induction therapy for adults with acute lymphoblastic leukemia (ALL)
Participants 1090 1145 4
trial accrued patients from August 1996 to October 2004
Participants 1147 1243 3
RESULTS The median follow-up for survivors was 7 years, and the median patient age was 43 years.
Participants 1244 1284 5
Responses were evaluated in 164 patients
Participants 1473 1553 3
More patients on the L-20 arm failed with resistant disease (21% vs 8%; P = .02)
